home · filing · 0001437749-23-016577
8-K filed June 5, 2023, 7:59 PM ET
ticker HSTM
CIK 0001095565
leadership
confidence high
sentiment neutral
materiality 0.25
HealthStream appoints Dr. Alex Jahangir to Board of Directors
HEALTHSTREAM INC
Dr. Jahangir appointed effective May 30, 2023 as Class II Director with term expiring at 2026 annual meeting.
He will serve on the Audit Committee and receive standard non-employee director compensation.
Dr. Jahangir is VP for business development at Vanderbilt University Medical Center and co-founder of Pendant Biosciences.
He previously chaired the Metropolitan Nashville COVID-19 Taskforce and appears often in national media.
No arrangements or transactions requiring disclosure under Item 404(a) exist.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Dr. Alex Jahangir
Director
Effective 2023-05-30
Filed June 5, 2023, 7:59 PM ET
On May 30, 2023, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Dr. Alex Jahangir as a member of the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Dr. Alex Jahangir was appointed as Director at HEALTHSTREAM INC.
Action appointed
Role Director
Exact text from the filing
On May 30, 2023, the Board of Directors (the “Board”) of HealthStream, Inc. (the “Company”) appointed Dr. Alex Jahangir as a member of the Board.
View on SEC.gov
Source: SEC EDGAR
accession 0001437749-23-016577
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.